Metropolis Healthcare Limited METROPOLIS.NS · Stock Open Metropolis Healthcare Limited in new tab
Metropolis Healthcare Limited Analysis (METROPOLIS.NS)
Is Metropolis Healthcare Limited a good investment? Metropolis Healthcare Limited (METROPOLIS.NS) is currently trading at 596.45 INR. Market analysts have a consensus price target of 615.51 INR. This suggests a potential upside from current levels.
In terms of valuation, the stock trades at a P/E ratio of 63.82. This high multiple suggests investors have priced in significant future growth expectations.
Earnings Schedule: Metropolis Healthcare Limited is expected to release its next earnings report on Aug. 7, 2026. The market consensus estimate for Forward EPS is 15.19.
For income investors, Metropolis Healthcare Limited pays a dividend yield of 0.34%.
Investor FAQ
Does Metropolis Healthcare Limited pay a dividend?
Yes, it pays an annual dividend of 2.00 INR (0.34% yield).
What asset class is Metropolis Healthcare Limited?
Metropolis Healthcare Limited is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.
When is the next earnings date?
The next earnings date is projected to be Aug. 7, 2026. The company currently has a trailing EPS of 9.17.
Company Profile
Metropolis Healthcare Limited, together with its subsidiaries, provides pathology and related healthcare services in India and internationally. The company offers routine and specialised pathology tests; advanced diagnostics, including genetic, molecular, and cytogenetic testing; preventive healthcare packages and corporate wellness screening; clinical trial research, hospital lab management, and home collection services; radiology services, including X-ray, sonography and ECG; and next-generation sequencing services. It also provides diagnostic services for oncology, chronic and infectious diseases, gastroenterology, neurology, nephrology, and women and child health, as well as various health checkup and laboratory services. The company serves a range of customers, including direct-to-consumer diagnostics through patient service centers, mobile app, website, and home collection; partnerships with standalone labs, hospital chains, and diagnostic networks; and institutional clients, such as corporates, government bodies, and hospital lab management services. Metropolis Healthcare Limited was founded in 1980 and is headquartered in Mumbai, India.
| Year | Total Dividends |
|---|---|
| ▸2027 |
1.00 INR
|
| June 14, 2027 (estimated) | 1.0000 |
| ▸2026 |
5.00 INR
|
| Dec. 4, 2026 (estimated) | 4.0000 |
| June 12, 2026 | 1.0000 |
| ▸2025 |
4.00 INR
|
| Dec. 4, 2025 | 4.0000 |
| ▸2023 |
12.00 INR
|
| Nov. 28, 2023 | 4.0000 |
| March 12, 2023 | 8.0000 |
| ▸2022 |
8.00 INR
|
| March 13, 2022 | 8.0000 |
| ▸2021 |
8.00 INR
|
| March 3, 2021 | 8.0000 |
| ▸2020 |
8.00 INR
|
| Feb. 24, 2020 | 8.0000 |
| Name | Payment Date | Status | Amount |
|---|---|---|---|
| Metropolis Healthcare Limited | Jun 12, 2026 | Paid | 1.0 INR |
| Metropolis Healthcare Limited | Dec 04, 2025 | Paid | 4.0 INR |
Community Discussion